Status:

COMPLETED

Safety and Efficacy Study of Umbilical Cord Blood-Drived Mesenchymal Stem Cells to Promote Engraftment of Unrelated Hematopoietic Stem Cell Transplantation

Lead Sponsor:

Medipost Co Ltd.

Conditions:

Acute Leukemia

Eligibility:

All Genders

2-19 years

Phase:

PHASE1

PHASE2

Brief Summary

The purpose of this study is to evaluate the safety and efficacy of PROMOSTEM (human umbilical cord blood-derived mesenchymal stem cells) at a dose of 1 and 5x1,000,000 hMSC/kg in subject for the prom...

Detailed Description

* Hematopoietic stem cell transplantation (HSCT) is a procedure in which progenitor cells capable of reconstituting normal bone marrow function are administered to a patient. This procedure has been u...

Eligibility Criteria

Inclusion

  • Patient age 2\~19 years old with plan to have unrelated hematopoietic stem cell transplantation with acute leukemia
  • Patient never has an experience of hematopoietic stem cell transplantation
  • Patient must have an acute leukemia with a complete remission.
  • Patients must have an ECOG 0\~2.
  • No moderate or sever organ dysfunction : Ejection fraction \> 45%; Creatinine \<2.0 mg/ml; Serum bilirubin \< 2 mg/ml; AST/ALT \< 200 IU/L.
  • Patient must not have an transplantation with different source of hematopoietic stem cell such as bone marrow and cord blood.
  • Patient must not have an infection needed an administration of non-oral antibiotics.
  • No active severe infection derived form virus or fungus.
  • Each patient / patient's guardian must sign written informed consent.

Exclusion

  • Patient has previously received hematopoietic stem cell transplantation.
  • Patient plans to have a related hematopoietic stem cell transplantation.
  • Patient has a severe internal disease.
  • Patient has enrolled another clinical trial study within last 4 weeks.

Key Trial Info

Start Date :

August 1 2008

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

February 1 2010

Estimated Enrollment :

10 Patients enrolled

Trial Details

Trial ID

NCT00823316

Start Date

August 1 2008

End Date

February 1 2010

Last Update

April 23 2012

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Samsung Medical Center

Seoul, South Korea, 135-710

Safety and Efficacy Study of Umbilical Cord Blood-Drived Mesenchymal Stem Cells to Promote Engraftment of Unrelated Hematopoietic Stem Cell Transplantation | DecenTrialz